WESTLAKE VILLAGE, Calif., Dec. 17, 2003 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFV), manufacturer, distributor and marketer of biomedical diagnostics and NICOWater(tm), a Homeopathic Nicotinum Formula, today announced that the Maine Legislative Committee on Health and Human Services has decided to table LD 1631 "An Act to Prevent the Sale of Water Laced with Nicotine in Maine."
QT 5, Inc. President Steven H. Reder said, "We have always felt confident that NICOWater is a legitimate product that provides adult smokers with an alternative to relieve the symptoms of tobacco cravings when they find themselves in situations and environments where they cannot or should not smoke. In our efforts to support this position, our CEO, FDA Attorney and a contingent of our Medical Advisory Board even braved a blizzard to be present for the committee meeting. The result is very gratifying and serves to confirm our ability and commitment to overcome the anticipated challenges of pioneering a breakthrough product."
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing and Homeopathic products. QT 5, Inc. currently manufactures and markets NICOWater, its breakthrough Homeopathic Nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings. QT 5 continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: www.qt5inc.com . NICOWater is a Homeopathic Drug product that is sold under the FDA's Compliance Policy Guide Conditions Under Which Homeopathic Drugs May Be Marketed.
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward looking statements.